Find an Eye MD near you!

Citron Research accuses Canadian-based pharmaceutical company Valeant of massive fraud.

FDA has requested an additional information for Shire’s dry eye disease drug, lifitegrast.

Allergan Plc. has purchased AqueSys and its minimally invasive soft shunt for glaucoma, XEN45

Avedro has resubmitted a new drug application for its riboflavin opthalmic solution/KXL system for corneal cross-linking (CXL).

Dr. Sam Masket developed an IOL to prevent negative dysphotopsia, the dark or grey arc-shaped shadow seen in the temporal field of vision following uncomplicated cataract surgery.

The first clinical trial of an extended-release formulation of travoprost shows it’s comparable to topical once-daily travoprost in patients with glaucoma.